March 03, 2026 a 09:00 pm
CNC: Analysts Ratings - Centene Corporation
Centene Corporation, as a prominent entity in the healthcare market, engages in providing services to the under-insured and uninsured population in the U.S. The company's managed care and specialized services cater to diverse government programs. Despite a complex landscape, Centene has shown resilience and adaptability. The recent analyst ratings indicate a tilt towards caution, emphasizing 'Hold' decisions. Analysts are closely monitoring Centene's response to market dynamics and policy reforms.
Historical Stock Grades
| Recommendation | Count | Score Bar |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 3 | |
| Hold | 13 | |
| Sell | 1 | |
| Strong Sell | 1 |
Sentiment Development
Recent analyst data for Centene Corporation reveals a conservative shift in market sentiment. Over the months, 'Hold' ratings have increased, while 'Strong Buy' remains low. The trend suggests a cautious outlook, with potential concerns over market volatility.
- Significant rise in 'Hold' ratings from 7 to 14 over the past year.
- Decrease in 'Strong Buy' from 6 to 2, indicating reduced bullish sentiment.
- 'Sell' and 'Strong Sell' ratings remain minimal, showing limited negative outlook.
Percentage Trends
The allocation of ratings has notably shifted towards neutrality. Over the past year, 'Hold' recommendations dominate at 65%, showcasing a balanced stance amid uncertainties. This trend illustrates growing analyst caution, possibly driven by regulatory outlooks or financial performance reviews.
- 'Strong Buy' percentages decreased from 15% to 10% - a reduction in aggressive positive outlook.
- 'Hold' percentages increased from 35% to 65% - indicating strong cautious sentiment.
- 'Sell' and 'Strong Sell' remain collectively under 10%, suggesting limited downside risk concerns.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-02-18 | Equal Weight | Equal Weight | Wells Fargo |
| 2026-02-09 | Neutral | Neutral | Cantor Fitzgerald |
| 2026-01-07 | Equal Weight | Equal Weight | Wells Fargo |
| 2026-01-05 | Overweight | Equal Weight | Barclays |
| 2025-11-21 | Outperform | Outperform | Bernstein |
Analyst Recommendations with Change of Opinion
A review of changes indicates selective shifts in sentiment. While some analysts have upgraded CNC, others have opted for downgrades, reflecting varying perspectives on Centene's strategic direction and market conditions.
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-01-05 | Overweight | Equal Weight | Barclays |
| 2025-07-28 | Neutral | Overweight | Cantor Fitzgerald |
| 2025-07-23 | Equal Weight | Overweight | Wells Fargo |
| 2025-07-21 | Hold | Buy | TD Cowen |
| 2025-07-16 | Underperform | Neutral | B of A Securities |
Interpretation
The prevailing analyst sentiment for Centene Corporation indicates a neutral to slightly cautious outlook. The increase in 'Hold' ratings suggests analysts are uncertain about immediate growth prospects. While some confidence exists, as reflected in selective 'Overweight' recommendations, overall market sentiment leans towards a wait-and-see approach. Stability is seen in limited 'Sell' recommendations, indicating analysts neither foresee significant declines nor rapid growth.
Conclusion
Centene Corporation maintains a robust position in the healthcare industry, yet faces market skepticism reflected in a growing proportion of 'Hold' ratings. While there is restrained enthusiasm shown in lowered 'Strong Buy' recommendations, optimism persists amid minimal 'Sell' signals. Analysts appear to observe Centene's strategic initiatives and sector dynamics closely, highlighting both opportunities and risks in this evolving market landscape.